Skip the primary navigation if you do not want to read it as the next section.
Skip the main content if you do not want to read it as the next section.
Moorfields is one of the world’s leading eye hospitals, providing expertise
in clinical care, research and education.
Our main focus is the
treatment and care of NHS patients with a wide range of eye problems, from
common complaints to rare conditions which require treatments not available
anywhere else in the UK.
We treat people at our main hospital in London’s City Road and at 21 other locations in and around the capital, which enables us to provide expert treatment closer to patients’ homes. Moorfields has contracts with more than 80 primary care trusts across the country, making us a truly national centre for eye care.
We are also a major postgraduate teaching centre and a national centre for
ophthalmic research involving, with the UCL Institute of Ophthalmology, the
largest ophthalmic research programme in the world.
In addition,
we directly manage three commercial divisions: Moorfields Private, Moorfields
Pharmaceuticals and Moorfields Eye Hospital Dubai.
Record
numbers of patient attendances
In 2010/11,
Moorfields handled more than 400,000 outpatient attendances in our clinics and
almost 75,000 visits to our specialist A&E department. We carried out
more than 30,000 inpatient and day-case procedures, around 11,000 laser
procedures and some 10,000 intra-vitreal injections.
A pioneering tradition
Moorfields has provided excellence
in eye care for more than 200 years and we continue to be at the forefront of
new breakthroughs and developments. In 2004, we became one of the
country's first NHS foundation trusts and we are an integral part of one of the
UK’s first academic health science centres, UCL Partners.
Cutting-edge research
We continue to make headlines with
our ground-breaking research. Along with our partners at the UCL
Institute of Ophthalmology, we have the highest measure of scientific
productivity and impact in the world for our research activity.
Solid performance on national targets
- More than 90% of admitted patients and 97% of non-admitted patients treated within 18 weeks of referral by a GP, exceeding the national targets
- Nearly all patients wait less than four hours in A&E
- No reported cases of either C-difficile or MRSA bloodstream infections to date
- Financial surplus achieved in 2010/11
